AC
EOLS icon

Apogem Capital’s Evolus EOLS Stock Holding History

Apogem Capital’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,407
Closed -$92K – 35
2022
Q3 		$92K Buy
+11,407
New +$121K 0.09% 131

Other funds holding EOLS

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Apogem Capital's EOLS Position: Q4 2022 in Review

Apogem Capital sold out of Evolus (EOLS) in Q4 2022, closing a stake of 11,407 shares — an estimated $92K sold.

Apogem Capital first reported a position in EOLS in Q3 2022 and held it in 1 quarter. The position peaked at $92K in Q3 2022. 120 funds tracked by Wall St. Rank hold EOLS as of Q4 2022.

  • Apogem Capital reported no remaining Evolus position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 11,407 Evolus shares in Q4 2022, an estimated $92K.
  • Apogem Capital first reported a position in Evolus in Q3 2022 and held it in 1 quarter.
  • Apogem Capital's Evolus position peaked at $92K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Evolus as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.